|
|
Gene Symbol |
AOPEP |
|
Aliases |
AP-O, APO, C90RF3, C9orf3, ONPEP |
|
Entrez Gene ID |
|
|
Gene Name |
Aminopeptidase O (putative) |
|
Chromosomal Location |
9q22.32 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Aminopeptidase O |
|
Function |
Aminopeptidases catalyze the hydrolysis of amino acid residues from the N-terminus of peptide or protein substrates. Able to cleave angiotensin III to generate angiotensin IV, a bioactive peptide of the renin-angiotensin pathway. Not able to cleave angiotensin I and angiotensin II. May play a role in the proteolytic processing of bioactive peptides in tissues such as testis and heart. |
|
|
|
|
|
UniProt |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000305422 |
P17676 |
P17676 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Atrial Fibrillation |
|
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
Juvenile arthritis |
|
Still Disease |
|
|
References |
|
|
Day Felix, Karaderi Tugce, Jones Michelle R, Meun Cindy, He Chunyan, Drong Alex, Kraft Peter, Lin Nan, Huang Hongyan, Broer Linda, Magi Reedik, Saxena Richa, Laisk Triin, Urbanek Margrit, Hayes M Geoffrey, Thorleifsson Gudmar, Fernandez-Tajes Juan, Mahajan Anubha, Mullin Benjamin H, Stuckey Bronwyn G A, Spector Timothy D, Wilson Scott G, Goodarzi Mark O, Davis Lea, Obermayer-Pietsch Barbara, Uitterlinden Andre G, Anttila Verneri, Neale Benjamin M, Jarvelin Marjo-Riitta, Fauser Bart, Kowalska Irina, Visser Jenny A, Andersen Marianne, Ong Ken, Stener-Victorin Elisabet, Ehrmann David, Legro Richard S, Salumets Andres, McCarthy Mark I, Morin-Papunen Laure, Thorsteinsdottir Unnur, Stefansson Kari, Styrkarsdottir Unnur, Perry John R B, Dunaif Andrea, Laven Joop, Franks Steve, Lindgren Cecilia M, Welt Corrine K |
MRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, Famagusta, Cyprus.| Center for Bioinformatics & Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.| Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.| Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.| University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States of America.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.| Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.| University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States of America.| Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.| Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.| Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.| Broad Institute of Harvard and MIT and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.| Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.| Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.| Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.| Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.| Department of Anthropology, Northwestern University, Evanston, Illinois, United States of America.| deCODE genetics/Amgen, Reykjavik, Iceland.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.| Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.| School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.| Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.| School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.| Keogh Institute for Medical Research, Nedlands, Western Australia, Australia.| Department of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom.| Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.| School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.| Department of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom.| Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.| Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.| Vanderbilt Genomics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.| Division of Endocrinology and Diabetology, Department of Internal Medicine Medical University of Graz, Graz, Austria.| Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.| Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.| Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.| Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.| Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.| Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.| Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.| Biocenter Oulu, University of Oulu, Oulu, Finland.| Unit of Primary Care, Oulu University Hospital, Oulu, Finland.| Department of Reproductive Medicine and Gynaecology, University Medical Center, Utrecht, The Netherlands.| Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.| Department of Internal Medicine, Section of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.| Odense University Hospital, University of Southern Denmark, Odense, Denmark.| MRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.| Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.| Department of Medicine, Section of Adult and Paediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, Illinois, United States of America.| Department of Obstetrics and Gynecology and Public Health Sciences, Penn State University College of Medicine, Hershey, Pennsylvania, United States of America.| Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.| Competence Centre on Health Technologies, Tartu, Estonia.| Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.| Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.| Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.| Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Medical Research Center, PEDEGO Research Unit, Oulu, Finland.| deCODE genetics/Amgen, Reykjavik, Iceland.| Faculty of Medicine, University of Iceland, Reykjavik, Iceland.| deCODE genetics/Amgen, Reykjavik, Iceland.| Faculty of Medicine, University of Iceland, Reykjavik, Iceland.| deCODE genetics/Amgen, Reykjavik, Iceland.| MRC Epidemiology Unit, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.| Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.| Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.| Institute of Reproductive & Developmental Biology, Department of Surgery & Cancer, Imperial College London, London, United Kingdom.| The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.| Broad Institute of Harvard and MIT and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.| Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.| Division of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah, United States of America.| Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America. |
PLoS Genet. 2018 Dec 19;14(12):e1007813. doi: 10.1371/journal.pgen.1007813. |
Abstract
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health. |
|
|
Hayes M Geoffrey, Urbanek Margrit, Ehrmann David A, Armstrong Loren L, Lee Ji Young, Sisk Ryan, Karaderi Tugce, Barber Thomas M, McCarthy Mark I, Franks Stephen, Lindgren Cecilia M, Welt Corrine K, Diamanti-Kandarakis Evanthia, Panidis Dimitrios, Goodarzi Mark O, Azziz Ricardo, Zhang Yi, James Roland G, Olivier Michael, Kissebah Ahmed H, Stener-Victorin Elisabet, Legro Richard S, Dunaif Andrea |
1] Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA [2] Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA [3] Department of Anthropology, Northwestern University, Evanston, Illinois 60208, USA.| 1] Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA [2] Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.| Section of Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, Illinois 60637, USA.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.| Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.| Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.| Warwick Medical School, University of Warwick, Warwick CV4 7AL, UK.| 1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK [2] Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK [3] Oxford NIHR Biomedical Research Centre, Churchill Hospital, Headington OX3 7LE, UK.| Institute of Reproductive &Developmental Biology, Hammersmith Hospital, Imperial College London, London W12 0NN, UK.| 1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK [2] Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.| Division of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah 84112, USA.| Endocrinology and Metabolism, University of Athens Medical School, Athens 115 27, Greece.| Division of Endocrinology and Human Reproduction, 2nd Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki 54124, Greece.| Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.| Departments of Obstetrics and Gynecology and Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia 30912, USA.| 1] TOPS Obesity and Metabolic Research Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA [2] Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.| 1] TOPS Obesity and Metabolic Research Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA [2] Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.| Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78256, USA.| 1] TOPS Obesity and Metabolic Research Center, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA [2] Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.| Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.| Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.| 1] Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA [2] Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. |
Nat Commun. 2015 Aug 18;6:7502. doi: 10.1038/ncomms8502. |
Abstract
Polycystic ovary syndrome (PCOS) is a common, highly heritable complex disorder of unknown aetiology characterized by hyperandrogenism, chronic anovulation and defects in glucose homeostasis. Increased luteinizing hormone relative to follicle-stimulating hormone secretion, insulin resistance and developmental exposure to androgens are hypothesized to play a causal role in PCOS. Here we map common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels. Three loci reach genome-wide significance in the case-control meta-analysis, two novel loci mapping to chr 8p23.1 [Corrected] and chr 11p14.1, and a chr 9q22.32 locus previously found in Chinese PCOS. The same chr 11p14.1 SNP, rs11031006, in the region of the follicle-stimulating hormone B polypeptide (FSHB) gene strongly associates with PCOS diagnosis and luteinizing hormone levels. These findings implicate neuroendocrine changes in disease pathogenesis. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|